Weiss Multi-Strategy Advisers’s ADMA Biologics ADMA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-20,000	Closed	-$74K	–	471
2017 Q2	$74K	Sell	20,000 -20,000	-50%	-$80.3K	﹤0.01%	503
2017 Q1	$195K	Sell	40,000 -60,000	-60%	-$296K	0.01%	515
2016 Q4	$512K	Sell	100,000 -17,000	-15%	-$97.6K	0.02%	324
2016 Q3	$847K	Sell	117,000 -25,155	-18%	-$160K	0.05%	304
2016 Q2	$846K	Sell	142,155 -2,845	-2%	-$19.9K	0.07%	281
2016 Q1	$1.17M	Sell	145,000 -15,000	-9%	-$85.7K	0.05%	322
2015 Q4	$1.29M	Buy	160,000 +6,000	+4%	+$54K	0.09%	215
2015 Q3	$1.29M	Buy	154,000 +64,000	+71%	+$591K	0.06%	234
2015 Q2	$833K	Buy	90,000 +36,900	+69%	+$319K	0.03%	332
2015 Q1	$520K	Buy	+53,100	New	+$535K	0.02%	358

Other funds holding ADMA

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

BCM

Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ADMA Position: Q3 2017 in Review

Weiss Multi-Strategy Advisers sold out of ADMA Biologics (ADMA) in Q3 2017, closing a stake of 20,000 shares — an estimated $74K sold.

Weiss Multi-Strategy Advisers first reported a position in ADMA in Q1 2015 and held it in 10 quarters. The position peaked at $1.29M in Q4 2015. 19 funds tracked by Wall St. Rank hold ADMA as of Q3 2017.

Weiss Multi-Strategy Advisers reported no remaining ADMA Biologics position as of Q3 2017 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 20,000 ADMA Biologics shares in Q3 2017, an estimated $74K.
Weiss Multi-Strategy Advisers first reported a position in ADMA Biologics in Q1 2015 and held it in 10 quarters.
Weiss Multi-Strategy Advisers's ADMA Biologics position peaked at $1.29M in Q4 2015.
19 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2017.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2017, filed 14 Nov 2017.